{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:10:50Z","timestamp":1778022650018,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"DOI":"10.7759\/cureus.108319","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:16:25Z","timestamp":1778019385000},"source":"Crossref","is-referenced-by-count":0,"title":["Water-Dispersible Palmitoylethanolamide (PEA) Supplementation for Functional Improvement in Adults With Chronic Sciatica-Related Back Pain: A Pilot Clinical Trial"],"prefix":"10.7759","author":[{"given":"Harshith N","family":"Raju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"International Association for the Study of Pain (IASP). terminology: pain . (2026). Accessed: 20\/02\/2026: https:\/\/www.iasp-pain.org\/resources\/terminology."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002291","article-title":"Prevalence of chronic pain among adults in the United States","volume":"163","author":"Yong RJ","year":"2022","unstructured":"Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022, 163:e328-32. 10.1097\/j.pain.0000000000002291","journal-title":"Pain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00098-X","article-title":"Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","unstructured":"Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050. a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023, 5:e316-29. 10.1016\/S2665-9913(23)00098-X","journal-title":"Lancet Rheumatol"},{"key":"ref4","unstructured":"World Health Organization (WHO). Low back pain. (2026). Accessed. 20\/02\/2026: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/low-back-pain."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/life13010084","article-title":"Mechanisms behind the development of chronic low back pain and its neurodegenerative features","volume":"13","author":"Mosabbir A","year":"2022","unstructured":"Mosabbir A. Mechanisms behind the development of chronic low back pain and its neurodegenerative features. Life (Basel). 2022, 13:10.3390\/life13010084","journal-title":"Life (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S306280","article-title":"Peripheral and central pathological mechanisms of chronic low back pain: a narrative review","volume":"14","author":"Li W","year":"2021","unstructured":"Li W, Gong Y, Liu J, et al.. Peripheral and central pathological mechanisms of chronic low back pain: a narrative review. J Pain Res. 2021, 14:1483-94. 10.2147\/JPR.S306280","journal-title":"J Pain Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1659531","article-title":"Efficacy and safety of pregabalin in the management of low back pain: a comprehensive meta-analysis","volume":"16","author":"Cordero-Garc\u00eda C","year":"2025","unstructured":"Cordero-Garc\u00eda C, S\u00e1nchez-Raya J, Rodr\u00edguez-Araya TL, L\u00f3pez-Alarc\u00f3n MD, Trillo-Calvo E, Balsalobre-Aznar J, P\u00e9rez-P\u00e1ramo M. Efficacy and safety of pregabalin in the management of low back pain: a comprehensive meta-analysis. Front Pharmacol. 2025, 16:1659531. 10.3389\/fphar.2025.1659531","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092175","article-title":"Therapeutic efficacy of palmitoylethanolamide and its new formulations in synergy with different antioxidant molecules present in diets","volume":"11","author":"Peritore AF","year":"2019","unstructured":"Peritore AF, Siracusa R, Crupi R, Cuzzocrea S. Therapeutic efficacy of palmitoylethanolamide and its new formulations in synergy with different antioxidant molecules present in diets. Nutrients. 2019, 11:10.3390\/nu11092175","journal-title":"Nutrients"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105305","article-title":"Palmitoylethanolamide: a natural compound for health management","volume":"22","author":"Clayton P","year":"2021","unstructured":"Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R. Palmitoylethanolamide: a natural compound for health management. Int J Mol Sci. 2021, 22:10.3390\/ijms22105305","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249526","article-title":"Palmitoylethanolamide: a nutritional approach to keep neuroinflammation within physiological boundaries-a systematic review","volume":"21","author":"Petrosino S","year":"2020","unstructured":"Petrosino S, Schiano Moriello A. Palmitoylethanolamide: a nutritional approach to keep neuroinflammation within physiological boundaries-a systematic review. Int J Mol Sci. 2020, 21:10.3390\/ijms21249526","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194084","article-title":"The effect of palmitoylethanolamide on pain intensity, central and peripheral sensitization, and pain modulation in healthy volunteers-a randomized, double-blinded, placebo-controlled crossover trial","volume":"14","author":"Lang-Illievich K","year":"2022","unstructured":"Lang-Illievich K, Klivinyi C, Rumpold-Seitlinger G, Dorn C, Bornemann-Cimenti H. The effect of palmitoylethanolamide on pain intensity, central and peripheral sensitization, and pain modulation in healthy volunteers-a randomized, double-blinded, placebo-controlled crossover trial. Nutrients. 2022, 14:10.3390\/nu14194084","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217942","article-title":"The basal pharmacology of palmitoylethanolamide","volume":"21","author":"Rankin L","year":"2020","unstructured":"Rankin L, Fowler CJ. The basal pharmacology of palmitoylethanolamide. Int J Mol Sci. 2020, 21:10.3390\/ijms21217942","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/plants11202721","article-title":"A Review of the chemistry and biological activities of Acmella oleracea (\"jamb\u00f9\", Asteraceae), with a view to the development of bioinsecticides and acaricides","volume":"11","author":"Spinozzi E","year":"2022","unstructured":"Spinozzi E, Ferrati M, Baldassarri C, et al.. A Review of the chemistry and biological activities of Acmella oleracea (\"jamb\u00f9\", Asteraceae), with a view to the development of bioinsecticides and acaricides. Plants (Basel). 2022, 11:10.3390\/plants11202721","journal-title":"Plants (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2022.2142221","article-title":"Alkylamides from Acmella oleracea: antinociceptive effect and molecular docking with cannabinoid and TRPV1 receptors","volume":"37","author":"Yien RM","year":"2023","unstructured":"Yien RM, Gomes AC, Goetze Fiorot R, et al.. Alkylamides from Acmella oleracea: antinociceptive effect and molecular docking with cannabinoid and TRPV1 receptors. Nat Prod Res. 2023, 37:3136-44. 10.1080\/14786419.2022.2142221","journal-title":"Nat Prod Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0837-0","article-title":"Spilanthol inhibits COX-2 and ICAM-1 expression via suppression of NF-\u03baB and MAPK signaling in interleukin-1\u03b2-stimulated human lung epithelial cells","volume":"41","author":"Huang WC","year":"2018","unstructured":"Huang WC, Wu LY, Hu S, Wu SJ. Spilanthol inhibits COX-2 and ICAM-1 expression via suppression of NF-\u03baB and MAPK signaling in interleukin-1\u03b2-stimulated human lung epithelial cells. Inflammation. 2018, 41:1934-44. 10.1007\/s10753-018-0837-0","journal-title":"Inflammation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.07.012","article-title":"Asking the community about cutpoints used to describe mild, moderate, and severe pain","volume":"7","author":"Palos GR","year":"2006","unstructured":"Palos GR, Mendoza TR, Mobley GM, Cantor SB, Cleeland CS. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006, 7:49-56. 10.1016\/j.jpain.2005.07.012","journal-title":"J Pain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.10.034","article-title":"Using screening tools to identify neuropathic pain","volume":"127","author":"Bennett MI","year":"2007","unstructured":"Bennett MI, Attal N, Backonja MM, et al.. Using screening tools to identify neuropathic pain. Pain. 2007, 127:199-203. 10.1016\/j.pain.2006.10.034","journal-title":"Pain"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira D","year":"2005","unstructured":"Bouhassira D, Attal N, Alchaar H, et al.. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114:29-36. 10.1016\/j.pain.2004.12.010","journal-title":"Pain"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196773","article-title":"The enteric glia and its modulation by the endocannabinoid system, a new target for cannabinoid-based nutraceuticals?","volume":"27","author":"L\u00f3pez-G\u00f3mez L","year":"2022","unstructured":"L\u00f3pez-G\u00f3mez L, Szymaszkiewicz A, Zieli\u0144ska M, Abalo R. The enteric glia and its modulation by the endocannabinoid system, a new target for cannabinoid-based nutraceuticals?. Molecules. 2022, 27:10.3390\/molecules27196773","journal-title":"Molecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S540327","article-title":"Palmitoylethanolamide in the treatment of pain and its clinical application prospects","volume":"19","author":"Wang Y","year":"2025","unstructured":"Wang Y, Duan X, Li Z, Pan Y, Deng J. Palmitoylethanolamide in the treatment of pain and its clinical application prospects. Drug Des Devel Ther. 2025, 19:6897-923. 10.2147\/DDDT.S540327","journal-title":"Drug Des Devel Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1021\/jf073057e","article-title":"Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators","volume":"56","author":"Wu LC","year":"2008","unstructured":"Wu LC, Fan NC, Lin MH, Chu IR, Huang SJ, Hu CY, Han SY. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators. J Agric Food Chem. 2008, 56:2341-9. 10.1021\/jf073057e","journal-title":"J Agric Food Chem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmpt.2004.02.002","article-title":"Low back pain in Australian adults: prevalence and associated disability","volume":"27","author":"Walker BF","year":"2004","unstructured":"Walker BF, Muller R, Grant WD. Low back pain in Australian adults: prevalence and associated disability. J Manipulative Physiol Ther. 2004, 27:238-44. 10.1016\/j.jmpt.2004.02.002","journal-title":"J Manipulative Physiol Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2018.07.006","article-title":"Prevalence and profile of high-impact chronic pain in the United States","volume":"20","author":"Pitcher MH","year":"2019","unstructured":"Pitcher MH, Von Korff M, Bushnell MC, Porter L. Prevalence and profile of high-impact chronic pain in the United States. J Pain. 2019, 20:146-60. 10.1016\/j.jpain.2018.07.006","journal-title":"J Pain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.09.010","article-title":"Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with disc herniation and degenerative disc disease","volume":"75","author":"Palada V","year":"2019","unstructured":"Palada V, Ahmed AS, Finn A, Berg S, Svensson CI, Kosek E. Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with disc herniation and degenerative disc disease. Brain Behav Immun. 2019, 75:60-71. 10.1016\/j.bbi.2018.09.010","journal-title":"Brain Behav Immun"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v16.i1.102120","article-title":"Role of neurogenic inflammation in intervertebral disc degeneration","volume":"16","author":"Peng BG","year":"2025","unstructured":"Peng BG, Li YC, Yang L. Role of neurogenic inflammation in intervertebral disc degeneration. World J Orthop. 2025, 16:102120. 10.5312\/wjo.v16.i1.102120","journal-title":"World J Orthop"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39657-6","article-title":"Behavioral compensations and neuronal remodeling in a rodent model of chronic intervertebral disc degeneration","volume":"9","author":"Leimer EM","year":"2019","unstructured":"Leimer EM, Gayoso MG, Jing L, Tang SY, Gupta MC, Setton LA. Behavioral compensations and neuronal remodeling in a rodent model of chronic intervertebral disc degeneration. Sci Rep. 2019, 9:3759. 10.1038\/s41598-019-39657-6","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000164099.92112.29","article-title":"Responsiveness of the numeric pain rating scale in patients with low back pain","volume":"30","author":"Childs JD","year":"2005","unstructured":"Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine (Phila Pa 1976). 2005, 30:1331-4. 10.1097\/01.brs.0000164099.92112.29","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/09593985.2017.1345025","article-title":"Does early change predict long-term (6 months) improvements in subjects who receive manual therapy for low back pain?","volume":"33","author":"Cook C","year":"2017","unstructured":"Cook C, Petersen S, Donaldson M, Wilhelm M, Learman K. Does early change predict long-term (6 months) improvements in subjects who receive manual therapy for low back pain?. Physiother Theory Pract. 2017, 33:716-24. 10.1080\/09593985.2017.1345025","journal-title":"Physiother Theory Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14020380","article-title":"Phospholipid-based delivery system optimizes the solubility and systemic exposure of palmitoylethanolamide and supports clinical benefits in chronic neuropathic low back pain","volume":"14","author":"Khan A","year":"2026","unstructured":"Khan A, Rabbani F, Kanwal A, et al.. Phospholipid-based delivery system optimizes the solubility and systemic exposure of palmitoylethanolamide and supports clinical benefits in chronic neuropathic low back pain. Biomedicines. 2026, 14:10.3390\/biomedicines14020380","journal-title":"Biomedicines"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051250","article-title":"Effective management of chronic low back pain in the elderly: a one-year cohort study of oxygen-ozone therapy under CT guidance combined with alpha lipoic acid, palmitoylethanolamide, and myrrh","volume":"13","author":"Bonetti M","year":"2025","unstructured":"Bonetti M, Frigerio M, Ottaviani GM, et al.. Effective management of chronic low back pain in the elderly: a one-year cohort study of oxygen-ozone therapy under CT guidance combined with alpha lipoic acid, palmitoylethanolamide, and myrrh. Biomedicines. 2025, 13:10.3390\/biomedicines13051250","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485986-water-dispersible-palmitoylethanolamide-pea-supplementation-for-functional-improvement-in-adults-with-chronic-sciatica-related-back-pain-a-pilot-clinical-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:16:29Z","timestamp":1778019389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485986-water-dispersible-palmitoylethanolamide-pea-supplementation-for-functional-improvement-in-adults-with-chronic-sciatica-related-back-pain-a-pilot-clinical-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.108319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}